van der Helm-van Mil AH - Search Results

1

Comparison of methodologies for analysing the progression of joint destruction in rheumatoid arthritis.

Knevel R, Tsonaka R, le Cessie S, van der Linden MP, Huizinga TW, van der Heijde DM, Houwing-Duistermaat JJ, van der Helm-van Mil AH. Knevel R, et al. Scand J Rheumatol. 2013;42(3):182-9. doi: 10.3109/03009742.2012.728618. Epub 2013 Feb 20. Scand J Rheumatol. 2013. PMID: 23425151

2

No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes.

van der Helm-van Mil AH, Dieudé P, Schonkeren JJ, Cornélis F, Huizinga TW. van der Helm-van Mil AH, et al. Rheumatology (Oxford). 2004 Oct;43(10):1232-4. doi: 10.1093/rheumatology/keh314. Epub 2004 Jul 13. Rheumatology (Oxford). 2004. PMID: 15252214

3

Understanding the genetic contribution to rheumatoid arthritis.

van der Helm-van Mil AH, Wesoly JZ, Huizinga TW. van der Helm-van Mil AH, et al. Curr Opin Rheumatol. 2005 May;17(3):299-304. doi: 10.1097/01.bor.0000160780.13012.be. Curr Opin Rheumatol. 2005. PMID: 15838240 Review.

4

Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis.

Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW. Tolboom TC, et al. Arthritis Rheum. 2005 Jul;52(7):1999-2002. doi: 10.1002/art.21118. Arthritis Rheum. 2005. PMID: 15986342

5

Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles.

Linn-Rasker SP, van der Helm-van Mil AH, van Gaalen FA, Kloppenburg M, de Vries RR, le Cessie S, Breedveld FC, Toes RE, Huizinga TW. Linn-Rasker SP, et al. Ann Rheum Dis. 2006 Mar;65(3):366-71. doi: 10.1136/ard.2005.041079. Epub 2005 Jul 13. Ann Rheum Dis. 2006. PMID: 16014670 Free PMC article.

6

An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.

van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. van der Helm-van Mil AH, et al. Arthritis Rheum. 2005 Sep;52(9):2637-44. doi: 10.1002/art.21272. Arthritis Rheum. 2005. PMID: 16142711

7

Association of the PTPN22 C1858T single-nucleotide polymorphism with rheumatoid arthritis phenotypes in an inception cohort.

Wesoly J, van der Helm-van Mil AH, Toes RE, Chokkalingam AP, Carlton VE, Begovich AB, Huizinga TW. Wesoly J, et al. Arthritis Rheum. 2005 Sep;52(9):2948-50. doi: 10.1002/art.21294. Arthritis Rheum. 2005. PMID: 16145680 No abstract available.

8

Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis.

Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, Schreuder GM, Breedveld FC, Huizinga TW, de Vries RR, Toes RE. Verpoort KN, et al. Arthritis Rheum. 2005 Oct;52(10):3058-62. doi: 10.1002/art.21302. Arthritis Rheum. 2005. PMID: 16200610

9

Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis.

van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. van der Helm-van Mil AH, et al. Arthritis Res Ther. 2005;7(5):R949-58. doi: 10.1186/ar1767. Epub 2005 Jun 14. Arthritis Res Ther. 2005. PMID: 16207336 Free PMC article.

10

Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.

Huizinga TW, Amos CI, van der Helm-van Mil AH, Chen W, van Gaalen FA, Jawaheer D, Schreuder GM, Wener M, Breedveld FC, Ahmad N, Lum RF, de Vries RR, Gregersen PK, Toes RE, Criswell LA. Huizinga TW, et al. Arthritis Rheum. 2005 Nov;52(11):3433-8. doi: 10.1002/art.21385. Arthritis Rheum. 2005. PMID: 16255021

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results